Back to today’s briefing

Story perspectives

FDA's Oversight Failures Allow Dangerous Drugs in U.S.

6/26/2025

39 6

Summary

Story summary

ProPublica's extensive 14-month investigation uncovered alarming gaps in the FDA's oversight of foreign drug manufacturers, especially in India. While the agency banned several unsafe factories, it still permitted over a dozen drugs from these sites to flood the U.S. market, prioritizing drug availability over safety, resulting in countless complaints, hospitalizations, and tragic fatalities.

1 of 1

Story summary

ProPublica's extensive 14-month investigation uncovered alarming gaps in the FDA's oversight of foreign drug manufacturers, especially in India. While the agency banned several unsafe factories, it still permitted over a dozen drugs from these sites to flood the U.S. market, prioritizing drug availability over safety, resulting in countless complaints, hospitalizations, and tragic fatalities.